Randomized phase 2 study of FcRn antagonist efgartigimod in generalized myasthenia gravis
FcRn拮抗剂efgartigimod治疗全身型重症肌无力的随机II期研究
期刊:Neurology
影响因子:8.5
doi:10.1212/WNL.0000000000007600
Howard, James F Jr; Bril, Vera; Burns, Ted M; Mantegazza, Renato; Bilinska, Malgorzata; Szczudlik, Andrzej; Beydoun, Said; Garrido, Francisco Javier Rodriguez De Rivera; Piehl, Fredrik; Rottoli, Mariarosa; Van Damme, Philip; Vu, Tuan; Evoli, Amelia; Freimer, Miriam; Mozaffar, Tahseen; Ward, E Sally; Dreier, Torsten; Ulrichts, Peter; Verschueren, Katrien; Guglietta, Antonio; de Haard, Hans; Leupin, Nicolas; Verschuuren, Jan J G M